BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ Citizens United for Research in Epilepsy - Cure Epilepsy Award |
  Research Funding ]
DTSTART;VALUE=DATE:20210111
DTSTAMP:20260506T135219Z
UID:723b7189dd4263c422e27cd60053620986c8e25be7bf03297fd2220f
CATEGORIES:Call for proposal
DESCRIPTION:Aim:  CURE funds research that has the potential to truly tra
 nsform and save lives. This investigator-initiated grant program seeks to 
 push the envelope and accelerate promising research leading to disease-mod
 ifying breakthroughs for people living with epilepsy. CURE Epilepsy priori
 tizes highly innovative\, risky\, paradigm-shifting projects that address 
 CURE Epilepsy’s mission to cure epilepsy\, affirming our core belief tha
 t the only acceptable final goal is “no seizures\, no side-effects.”\n
 \nThe following priority areas reflect CURE Epilepsy’s focus on advances
  that have the potential to truly transform and save lives. Prevention\, d
 isease modification and elimination are critical goals and consistent with
  our mission.\n\n	Transformative research to enhance our understanding of 
 the cellular\, molecular\, genetic and systems-level mechanisms that lead 
 to any of the epilepsies\, facilitating the continued investigation of dis
 ease-modifying or preventative strategies\n	Innovative approaches that can
  prevent\, modify and/or arrest the development of acquired epilepsy. Exam
 ples include epilepsy that develops after stroke\, tumor\, traumatic brain
  injury or infection\, including febrile infection-related epilepsy syndro
 me (FIRES) as well new-onset refractory status-epilepticus (NORSE)\n	Resea
 rch that will inform the development of novel therapies to prevent onset o
 r halt the progression of the severe pediatric epilepsies\n	Research focus
 ed on new\, effective treatments for the >30% of the epilepsy population w
 ho are pharmacoresistant\n	Novel research that furthers our understanding 
 of the causes and ultimate elimination of SUDEP\n	Translational\, clinical
 \, and clinically informed basic research that will facilitate understandi
 ng of the cellular-\, molecular-\, and systems-level mechanisms that under
 lie the relationships between sleep and epilepsy\n\n\nFunding:      
   max. $250\,000\n\nDuration:      2 years\n\nEligibility: This award
  is available to both established and early career investigators. Postdoct
 oral fellows may not apply for this award.\n\nHow to Apply: All applicants
  must submit a Letter of Intent (LOI). The LOI should clearly and succinct
 ly outline the specific aims and include a brief description of the justif
 ication and research plan according to the guidelines in the RFA. LOIs and
  full proposals (by invitation) must be submitted through proposalCENTRAL.
  To begin an application\, applicants will need to create a professional p
 rofile\, if one does not already exist. If EPFL will serve as your host in
 stitution\, please use the following institution name in proposalCENTRAL: 
 Ecole Polytechnique Fédérale de Lausanne EPFL. After the LOI has been ev
 aluated\, selected applicants will be invited to submit a full proposal. A
 t this stage\, a signature from an institutional representative will be re
 quired\; for this\, please contact the Research Office.\n\nDeadline\, Lett
 er of Intent: 11-January-2021 (9:00 PM ET)\n\nFurther information\n\n\n	Mo
 re information about the program is available here\n	The Request for Appli
 cations (RFA) can be found here\n	The application portal can be found here
 \n	For any other questions\, please contact the Research Office\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR